These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11266425)

  • 1. The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens.
    Cizman M; Pokorn M; Seme K; Orazem A; Paragi M
    J Antimicrob Chemother; 2001 Apr; 47(4):475-7. PubMed ID: 11266425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide resistance rates in respiratory pathogens in Slovenia following reduced macrolide use.
    Cizman M; Beović B; Seme K; Paragi M; Strumbelj I; Müller-Premru M; Cad-Pecar S; Pokorn M
    Int J Antimicrob Agents; 2006 Dec; 28(6):537-42. PubMed ID: 17101264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program.
    Beekmann SE; Heilmann KP; Richter SS; García-de-Lomas J; Doern GV;
    Int J Antimicrob Agents; 2005 Feb; 25(2):148-56. PubMed ID: 15664485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin.
    Felmingham D
    J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimicrobial activities of macrolides against recent clinical isolates, and analysis of resistant mechanisms].
    Okubo T; Iyobe S; Fujiki Y; Sagai H
    Jpn J Antibiot; 2003 Jun; 56(3):163-70. PubMed ID: 12942787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance patterns of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a prospective study in Murcia, Spain, 1983-1992.
    Gómez J; Ruiz-Gómez J; Hernández-Cardona JL; Núñez ML; Canteras M; Valdés M
    Chemotherapy; 1994; 40(5):299-303. PubMed ID: 7956452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolide resistance in Streptococci and Haemophilus influenzae.
    Bozdogan B; Appelbaum PC
    Clin Lab Med; 2004 Jun; 24(2):455-75. PubMed ID: 15177849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections.
    Felmingham D; Grüneberg RN
    J Antimicrob Chemother; 2000 Feb; 45(2):191-203. PubMed ID: 10660501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
    Biedenbach DJ; Jones RN; Lewis MT; Croco MA; Barrett MS
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-3 (1999-2002).
    Inoue M; Kaneko K; Akizawa K; Fujita S; Kaku M; Igari J; Yamaguchi K; Kohno S; Yamanaka K; Iinuma Y; Murase M; Yokoyama T; Asari S; Hirakata Y
    J Infect Chemother; 2006 Feb; 12(1):9-21. PubMed ID: 16506084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A multicenter study of the antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, and Moraxella catarrhalis from community acquired infections in Saitama, Japan].
    Yamaguchi T; Hashikita G; Ogino T; Yoshioka H; Shimojima M; Ikari H; Nose K; Mitsunori K; Watanabe N; Maesaki S
    Jpn J Antibiot; 2015 Oct; 68(5):275-84. PubMed ID: 26742285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis.
    Schmitz FJ; Schwarz S; Milatovic D; Verhoef J; Fluit AC
    J Antimicrob Chemother; 2002 Jul; 50(1):145-8. PubMed ID: 12096026
    [No Abstract]   [Full Text] [Related]  

  • 16. PROTEKT 1999-2000: a multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan.
    Inoue M; Kohno S; Kaku M; Yamaguchi K; Igari J; Yamanaka K
    Int J Infect Dis; 2005 Jan; 9(1):27-36. PubMed ID: 15603993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current in vitro sensitivity of the most frequent bacterial respiratory pathogens: clinical implications].
    Oteo J; Alós JI; Gómez-Garcés JL
    Med Clin (Barc); 2001 Apr; 116(14):541-9. PubMed ID: 11412622
    [No Abstract]   [Full Text] [Related]  

  • 18. Microbiological profile of telithromycin, the first ketolide antimicrobial.
    Felmingham D
    Clin Microbiol Infect; 2001; 7 Suppl 3():2-10. PubMed ID: 11523558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.
    Hoban DJ; Doern GV; Fluit AC; Roussel-Delvallez M; Jones RN
    Clin Infect Dis; 2001 May; 32 Suppl 2():S81-93. PubMed ID: 11320449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of bacterial pathogens in the oropharynx of healthy children.
    Liassine N; Gervaix A; Hegi R; Strautman G; Suter S; Auckenthaler R
    Eur J Clin Microbiol Infect Dis; 1999 Mar; 18(3):217-20. PubMed ID: 10357059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.